Radiation-induced premature ovarian failure: focus on the role of ovarian inflammatory signaling pathways
Mohamed, D., Mantawy, E., Said, R., Kassem, D., Gad, A., El-Demerdash, E. (2023). Radiation-induced premature ovarian failure: focus on the role of ovarian inflammatory signaling pathways. EKB Journal Management System, 7(2), 522-538. doi: 10.21608/aps.2023.251808.1147
Doaa H. Mohamed; Eman M. Mantawy; Riham S. Said; Dina H. Kassem; Amany M. Gad; Ebtehal El-Demerdash. "Radiation-induced premature ovarian failure: focus on the role of ovarian inflammatory signaling pathways". EKB Journal Management System, 7, 2, 2023, 522-538. doi: 10.21608/aps.2023.251808.1147
Mohamed, D., Mantawy, E., Said, R., Kassem, D., Gad, A., El-Demerdash, E. (2023). 'Radiation-induced premature ovarian failure: focus on the role of ovarian inflammatory signaling pathways', EKB Journal Management System, 7(2), pp. 522-538. doi: 10.21608/aps.2023.251808.1147
Mohamed, D., Mantawy, E., Said, R., Kassem, D., Gad, A., El-Demerdash, E. Radiation-induced premature ovarian failure: focus on the role of ovarian inflammatory signaling pathways. EKB Journal Management System, 2023; 7(2): 522-538. doi: 10.21608/aps.2023.251808.1147

Radiation-induced premature ovarian failure: focus on the role of ovarian inflammatory signaling pathways

Archives of Pharmaceutical Sciences Ain Shams University
Volume 7, Issue 2, December 2023, Page 522-538  XML PDF (635.64 K)
Document Type: Review Article
DOI: 10.21608/aps.2023.251808.1147
View on SCiNiTO View on SCiNiTO
Authors
Doaa H. Mohamed email 1; Eman M. Mantawy2; Riham S. Said3; Dina H. Kassemorcid 4; Amany M. Gadorcid 5, 6; Ebtehal El-Demerdash2
1Central Administration of Drug Control, Egyptian Drug Authority (EDA), Formerly NODCAR, Giza 11553, Egypt.
2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
3Department of Drug Radiation Research, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
4Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
5Department of Pharmacology & Toxicology Department, Faculty of Pharmacy, Sinai University (Kantara Branch) 41636, Egypt.
6Department of Pharmacology, Egyptian Drug Authority, EDA, Formerly NODCAR, Giza 11553, Egypt.
Abstract
Abstract
Radiation therapy, an effective treatment modality for many types of cancer, often carries a heavy cost for young women. In particular, those undergoing pelvic radiotherapy mostly experience sudden menopausal symptoms and premature ovarian failure (POF) impacting their reproductive health and overall quality of life. Upon radiation, excessive reactive oxygen species (ROS) are produced causing a state of oxidative stress to tissues. Following this, DNA is damaged augmenting subsequent inflammatory responses and further tissue damage. Mild inflammation is essential for the development and release of oocytes; however, Pro-longed inflammation is associated with poor quality oocytes and sometimes complete dysfunction of the ovaries, as excessively produced, pro-inflammatory cytokines like Tumor necrosis factor-alpha (TNF-α) and interleukins lead to compromised ovary functionality. This work aims at considering the radiation induced POF as an inflammatory process. It also covers key molecular pathways involved in this response like nuclear factor kappa-B (NFκ-b), Transforming growth factor-β (TGF-β), Mitogen-activated protein kinase (MAPK), Sirtuin 1 (SIRT1), Poly [ADP-ribose] polymerase 1 and insulin like growth factor-1 (IGF-1) in regulating inflammation. Eventually, understanding these interrelated pathways can provide researchers with valuable molecular targets that can be used to develop new protective agents for radiation induced POF and thus improve the quality of life for these patients.
Keywords:
Premature ovarian failure- Ionizing radiation- Inflammation
Keywords
Female infertility; gamma rays; Molecular targets; NF-κB; MAPK; TGF-β; SIRT1; IGF-1
Statistics
Article View: 228
PDF Download: 256